Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma.

BMC cancer - 12 Feb 2021

Xu Shifeng, Guo Yuan, Zeng Yanwu, Song Zhijian, Zhu Xiaodan, Fan Ning, Zhang Zhilei, Ren Guibing, Zang Yunjin, Rao Wei

Abstract excerpt

BACKGROUND: The goal of this study is to disclose the clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. METHODS: A total of 86 Chinese patients were enrolled in this study. A panel of 579 pan-cancer genes was sequenced for the qualified samples from these patients. Driver genes, actionability, and tumor mutational burden were inferred and compared...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bile Duct Neoplasms
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholangiocarcinoma

Share to High-Throughput Nucleotide Sequencing

Share to Molecular Targeted Therapy

Share to Neoplasm Staging

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 33579226
DOI: 10.1186/s12885-021-07792-x
PMCID: PMC7879680

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma.PMID 33579226Read ↗

Clinically significant shared and distinct genomic alterations in Chinese and Western patients with intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Characteristics of genomic alterations in Chinese cholangiocarcinoma patients.Semantic proximity Read ↗

Comprehensive genomic profile of cholangiocarcinomas in ChinaSemantic proximity Read ↗

Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western PatientsSemantic proximity Read ↗

Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.Semantic proximity Read ↗

Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience.Semantic proximity Read ↗

Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancerSemantic proximity Read ↗

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for InterventionSemantic proximity Read ↗

Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experienceSemantic proximity Read ↗

Genomic feature and potential therapeutic target for cholangiocarcinomaSemantic proximity Read ↗

Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients.Semantic proximity Read ↗

Molecular Profile and Prognostic Value of BAP1 Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.